| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |